OLIG2, which exhibited significantly different expression between GC-GBM and MS-GBM, is commonly expressed in glioma [24] and has also been identified as a transcription factor that reprograms differentiated GBM cells into stem-like cells [25]. The gene discussed is OLIG2; the disease is central nervous system cancer.